The DOI matches its Crossref record; 74 of the 75 references it cites were found in a registry or an index.
Central orexin (hypocretin) 2 receptor antagonism reduces ethanol self-administration, but not cue-conditioned ethanol-seeking, in ethanol-preferring rats
Open accessAbstract
Orexins are hypothalamic neuropeptides which bind to two G-protein-coupled receptors, orexin-1 (OX(1)R) and orexin-2 (OX(2)R) receptor. While a role for OX(1)R has been established in both ethanol reinforcement and ethanol-seeking behaviour, the role of OX(2)R in these behaviours is relatively less-studied. The aim of this study was to determine the role of central OX(2)R in ethanol-taking and ethanol-seeking behaviour. Indiana ethanol-preferring rats were trained to self-administer ethanol (10% w/v) or sucrose (0.7–1% w/v) in the presence of reward-associated cues before being implanted with indwelling guide cannulae. The selective OX(2)R antagonist TCS-OX2-29 was administered i.c.v. to assess its effect on operant self-administration and cue-induced reinstatement following extinction. Following i.c.v. injection TCS-OX2-29 reduced self-administration of ethanol, but not sucrose. Despite reducing ethanol self-administration, TCS-OX2-29 had no impact on cue-induced reinstatement of ethanol seeking. To determine where in the brain OX(2)R were acting to modulate ethanol self-administration, TCS-OX2-29 was microinjected into either the shell or core of the nucleus accumbens (NAc). Intra-NAc core, but not shell, infusions of TCS-OX2-29 decreased responding for ethanol. Importantly, the doses of TCS-OX2-029 used were non-sedating. Collectively, these findings implicate OX(2)R in the NAc in mediating the reinforcing effects of ethanol. This effect appears to be drug-specific as antagonism of central OX(2)R had no impact on sucrose self-administration. Thus, OX(2)R in addition to OX(1)R may represent a potential therapeutic target for the treatment of ethanol-use disorders. However, unlike OX(1)R, no impact of OX(2)R antagonism was observed on cue-induced reinstatement, suggesting a more prominent role for OX(2)R in ethanol self-administration compared to cue-conditioned ethanol-seeking.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Both Hcrt-1 and Hcrt-2 receptor blockade decreased alcohol self-administration in alcohol-preferring rats(Lawrence et al., 2006;Brown et al., 2013).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Brown et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richardson, J. A., Kozlowski, G. P., Wilson, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80949-6 · Cited by 5,501
The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity
de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X.-B., Foye, P. E., Danielson, P. E., Fukuhara, C., Battenberg, E. L. F., Gautvik, V. T., Bartlett, F. S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.322 · Cited by 3,878
Neurons containing hypocretin (orexin) project to multiple neuronal systems
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., & Kilduff, T. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09996.1998 · Cited by 3,466
Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., de Jong, P. J., Nishino, S., & Mignot, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81965-0 · Cited by 2,613
Differential expression of orexin receptors 1 and 2 in the rat brain
Marcus, J. N., Aschkenasi, C. J., Lee, C. E., Chemelli, R. M., Saper, C. B., Yanagisawa, M., & Elmquist, J. K. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1190 · Cited by 1,659
A role for lateral hypothalamic orexin neurons in reward seeking
Harris, G. C., Wimmer, M., & Aston-Jones, G. (2005) · Nature · doi:10.1038/nature04071 · Cited by 1,311
Cortico-Basal Ganglia Reward Network: Microcircuitry
Sesack, S. R., & Grace, A. A. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.93 · Cited by 985
Distribution of orexin receptor mRNA in the rat brain
Trivedi, P. G., Yu, H., MacNeil, D. J., der Ploeg, L. H. T. V., & Guan, X.-M. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01266-6 · Cited by 979
Borgland, S. L., Taha, S. A., Sarti, F., Fields, H. L., & Bonci, A. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.016 · Cited by 718
Cited by
Sorted by citations
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases
Wang, C., Wang, Q., Ji, B., Pan, Y., Xu, C., Cheng, B., Bai, B., & Chen, J. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00220 · Cited by 219
Orexin/hypocretin role in reward: implications for opioid and other addictions
Baimel, C., Bartlett, S. E., Chiou, L., Lawrence, A. J., Muschamp, J. W., Patkar, O. L., Tung, L.-W., & Borgland, S. L. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12639 · Cited by 183
Self-citationA Decade of Orexin/Hypocretin and Addiction: Where Are We Now?
James, M. H., Mahler, S. V., Moorman, D. E., & Aston‐Jones, G. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_57 · Cited by 175
Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder
Burnette, E. M., Nieto, S. J., Grodin, E. N., Meredith, L. R., Hurley, B., Miotto, K., Gillis, A. J., & Ray, L. A. (2022) · Drugs · doi:10.1007/s40265-021-01670-3 · Cited by 169
Barson, J. R., Ho, H. T., & LEIBOWITZ, S. F. (2014) · Addiction Biology · doi:10.1111/adb.12139 · Cited by 134
Role of cues and contexts on drug‐seeking behaviour
Perry, C. J., Zbukvic, I., Kim, J. H., & Lawrence, A. J. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12735 · Cited by 141
Self-citationOrexins and fear: Implications for the treatment of anxiety disorders
Flores, Á., Saravia, R., Maldonado, R., & Berrendero, F. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.06.005 · Cited by 102
Anderson, R. I., Becker, H. C., Adams, B. L., Jesudason, C. D., & Rorick‐Kehn, L. M. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00033 · Cited by 97
Medications for alcohol use disorders: An overview
Akbar, M. D., Egli, M., Cho, Y., Song, B., & Noronha, A. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.11.007 · Cited by 101
Moorman, D. E., James, M. H., Kilroy, E. A., & Aston‐Jones, G. (2016) · Brain Research · doi:10.1016/j.brainres.2016.10.018 · Cited by 89
Orexin antagonists for neuropsychiatric disease: progress and potential pitfalls
Yeoh, J. W., Campbell, E. J., James, M. H., Graham, B. A., & Dayas, C. V. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00036 · Cited by 90
Prince, C. D., Rau, A. R., Yorgason, J. T., & España, R. A. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500246j · Cited by 83
Matzeu, A., Zamora-Martinez, E. R., & Martin‐Fardon, R. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00117 · Cited by 84
Mehr, J. B., Mitchison, D., Bowrey, H. E., & James, M. H. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01052-z · Cited by 71
Brown, R. M., Kim, A. K., Khoo, S. Y., Kim, J. H., Jupp, B., & Lawrence, A. J. (2015) · Addiction Biology · doi:10.1111/adb.12251 · Cited by 64
Self-citationOrexin/Hypocretin System: Role in Food and Drug Overconsumption
Barson, J. R., & LEIBOWITZ, S. F. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.06.006 · Cited by 67
Reichelt, A. C., Westbrook, R. F., & Morris, M. J. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13321 · Cited by 62
Moorman, D. E., James, M. H., Kilroy, E. A., & Aston‐Jones, G. (2016) · European Journal of Neuroscience · doi:10.1111/ejn.13170 · Cited by 64
Orexin/Hypocretin Based Pharmacotherapies for the Treatment of Addiction: DORA or SORA?
Khoo, S. Y., & Brown, R. M. (2014) · CNS Drugs · doi:10.1007/s40263-014-0179-x · Cited by 62
Self-citationRecent perspectives on orexin/hypocretin promotion of addiction-related behaviors
Hopf, F. W. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108013 · Cited by 63
Therapeutics development for addiction: Orexin-1 receptor antagonists
Perrey, D. A., & Zhang, Y. (2018) · Brain Research · doi:10.1016/j.brainres.2018.08.025 · Cited by 58
Hypothalamic neuropeptide signaling in alcohol addiction
Barson, J. R., & LEIBOWITZ, S. F. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.02.006 · Cited by 57
Martin‐Fardon, R., Cauvi, G., Kerr, T. M., & Weiss, F. (2016) · Addiction Biology · doi:10.1111/adb.12441 · Cited by 57
A sleeping giant: Suvorexant for the treatment of alcohol use disorder?
Campbell, E. J., Marchant, N. J., & Lawrence, A. J. (2018) · Brain Research · doi:10.1016/j.brainres.2018.08.005 · Cited by 55
Self-citationDrug addiction: An affective-cognitive disorder in need of a cure
Fattore, L., & Diana, M. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.04.006 · Cited by 58
Orexin/hypocretin and dysregulated eating: Promotion of foraging behavior
Barson, J. R. (2018) · Brain Research · doi:10.1016/j.brainres.2018.08.018 · Cited by 53
Nucleus incertus Orexin2 receptors mediate alcohol seeking in rats
Kastman, H. E., Błasiak, A., Walker, L. C., Siwiec, M., Krstew, E., Gundlach, A. L., & Lawrence, A. J. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.07.006 · Cited by 53
Self-citationHow contexts promote and prevent relapse to drug seeking
Khoo, S. Y., Gibson, G. D., Prasad, A. A., & McNally, G. P. (2016) · Genes Brain & Behavior · doi:10.1111/gbb.12328 · Cited by 54
Self-citationCh’ng, S. S., & Lawrence, A. J. (2015) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2015.03.002 · Cited by 52
Self-citationMohammadkhani, A., James, M. H., Pantazis, C. B., & Aston‐Jones, G. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146461 · Cited by 48
Ten-Blanco, M., Flores, Á., Cristino, L., Pereda-Pérez, I., & Berrendero, F. (2023) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2023.101066 · Cited by 48
Dynorphin and its role in alcohol use disorder
Karkhanis, A. N., & Al-Hasani, R. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146742 · Cited by 47
The Role of Orexins/Hypocretins in Alcohol Use and Abuse
Walker, L. C., & Lawrence, A. J. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_55 · Cited by 43
Self-citationLei, K., Wegner, S. A., Yu, J. H., Mototake, A., Hu, B., & Hopf, F. W. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00400 · Cited by 43
Knockdown of hypocretin attenuates extended access of cocaine self-administration in rats
Schmeichel, B. E., Matzeu, A., Koebel, P., Vendruscolo, L. F., Sidhu, H., Shahryari, R., Kieffer, B. L., Koob, G. F., Martin‐Fardon, R., & Contet, C. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0054-4 · Cited by 42
Orexin-1 receptor blockade suppresses compulsive-like alcohol drinking in mice
Lei, K., Wegner, S. A., Yu, J.-H., & Hopf, F. W. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.08.008 · Cited by 41
Lei, K., Kwok, C., Darevsky, D. M., Wegner, S. A., Yu, J.-H., Nakayama, L., Pedrozo, V., Anderson, L., Ghotra, S., Fouad, M., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00088 · Cited by 36
Matzeu, A., & Martin‐Fardon, R. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107906 · Cited by 36
Matzeu, A., & Martin‐Fardon, R. (2020) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2020.599710 · Cited by 36
Matzeu, A., & Martin‐Fardon, R. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.787595 · Cited by 35
Orexins (hypocretins): The intersection between homeostatic and hedonic feeding
Muthmainah, M., Gogos, A., Sumithran, P., & Brown, R. M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15328 · Cited by 32
Self-citationZlebnik, N. E., Holtz, N. A., Lepak, V. C., Saykao, A. T., Zhang, Y., & Carroll, M. E. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108719 · Cited by 30
A systematic review and meta-analysis on the transcriptomic signatures in alcohol use disorder
Friske, M. M., Torrico, E. C., Haas, M. J. W., Borruto, A. M., Giannone, F., Hade, A.-C., Yu, Y., Gao, L., Sutherland, G. T., HITZEMANN, R. J., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02719-x · Cited by 33
The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders
Moorman, D. E. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4871-2 · Cited by 31
Identification of discrete, intermingled hypocretin neuronal populations
Iyer, M., Essner, R. A., Klingenberg, B., & Carter, M. E. (2018) · The Journal of Comparative Neurology · doi:10.1002/cne.24490 · Cited by 27
James, M. H., Fragale, J. E. C., O’Connor, S. L., Zimmer, B. A., & Aston‐Jones, G. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108359 · Cited by 30
At the intersection of sleep deficiency and opioid use: mechanisms and therapeutic opportunities
Greenwald, M. K., Moses, T. E. H., & Roehrs, T. (2021) · Translational research · doi:10.1016/j.trsl.2021.03.006 · Cited by 29
Vaseghi, S., Zarrabian, S., & Haghparast, A. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.104516 · Cited by 29
Sadeghzadeh, F., Namvar, P., Naghavi, F. S., & Haghparast, A. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.12.005 · Cited by 28
Suvorexant to treat alcohol use disorder and comorbid insomnia: Plan for a phase II trial
Campbell, E. J., Norman, A. F., Bonomo, Y. A., & Lawrence, A. J. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146597 · Cited by 27
Self-citationSánchez-Alavez, M., Benedict, J., Wills, D. N., & Ehlers, C. L. (2019) · SLEEP · doi:10.1093/sleep/zsz020 · Cited by 26
Giannotti, G., Mottarlini, F., Heinsbroek, J. A., Mandel, M. R., James, M. H., & Peters, J. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02161-z · Cited by 25
James, M. H., & Aston‐Jones, G. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146665 · Cited by 23
Carvajal, F., Alcaráz-Iborra, M., Lerma-Cabrera, J. M., Valor, L. M., de la Fuente, L., Sanchez-Amate, M. D. C., & Cubero, I. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.03.046 · Cited by 24
Flores‐Ramirez, F. J., Illenberger, J. M., Pascasio, G., Matzeu, A., Mason, B. J., & Martin‐Fardon, R. (2022) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2022.1085882 · Cited by 24
Orexin in Patients with Alcohol Dependence Treated for Relapse Prevention: A Pilot Study
Ziółkowski, M., Czarnecki, D., Budzyński, J., Rosińska, Z., Żekanowska, E., & Góralczyk, B. (2015) · Alcohol and Alcoholism · doi:10.1093/alcalc/agv129 · Cited by 27
Illenberger, J. M., Flores‐Ramirez, F. J., Matzeu, A., Mason, B. J., & Martin‐Fardon, R. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1127735 · Cited by 21
Cannella, N., Ubaldi, M., Masi, A., Bramucci, M., Roberto, M., Bifone, A., & Ciccocioppo, R. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.05.014 · Cited by 24
Kwok, C., Lei, K., Pedrozo, V., Anderson, L., Ghotra, S., Walsh, M. M., Li, L., Yu, J.-H., & Hopf, F. W. (2021) · Scientific Reports · doi:10.1038/s41598-020-79935-2 · Cited by 18
Sahafzadeh, M., Karimi‐Haghighi, S., Mousavi, Z., & Haghparast, A. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.12.008 · Cited by 22
Gargiulo, A. T., Pirino, B. E., Curtis, G. R., & Barson, J. R. (2020) · Addiction Biology · doi:10.1111/adb.12972 · Cited by 21
Ardeshiri, M. R., Hosseinmardi, N., & Akbari, E. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.03.004 · Cited by 20
Contribution of hypothalamic orexin (hypocretin) circuits to pathologies of motivation
Mohammadkhani, A., Mitchell, C. S., James, M. H., Borgland, S. L., & Dayas, C. V. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17325 · Cited by 21
Alcaráz-Iborra, M., Navarrete, F., Rodríguez‐Ortega, E., de la Fuente, L., Manzanares, J., & Cubero, I. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00186 · Cited by 18
Alcaráz-Iborra, M., & Cubero, I. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.04.012 · Cited by 15
Ehlers, C. L., Benedict, J., Wills, D. N., & Sánchez-Alavez, M. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05371-4 · Cited by 13
The influence of orexins on ethanol-induced behavioral sensitization in male mice
Macedo, G. C., Kawakami, S. E., Vignoli, T., Sinigaglia‐Coimbra, R., & Suchecki, D. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.07.010 · Cited by 13
Mendoza-Ruiz, L. G., Vázquez-León, P., Martínez-Mota, L., Juan, E. R., & Miranda-Páez, A. (2018) · Alcohol · doi:10.1016/j.alcohol.2018.01.008 · Cited by 11
Aldridge, G. M., Zarin, T. A., Brandner, A. J., George, O., Gilpin, N. W., Repunte‐Canonigo, V., Sanna, P. P., Koob, G. F., Vendruscolo, L. F., & Schmeichel, B. E. (2022) · Addiction Neuroscience · doi:10.1016/j.addicn.2022.100028 · Cited by 11
Emerging targets for addiction neuropharmacology
Ubaldi, M., Cannella, N., & Ciccocioppo, R. (2015) · Progress in brain research · doi:10.1016/bs.pbr.2015.07.018 · Cited by 11
Orexin-mediated motivated arousal and reward seeking
Bjorness, T. E., & Greene, R. W. (2024) · Peptides · doi:10.1016/j.peptides.2024.171280 · Cited by 10
Orexin receptors: possible therapeutic targets for psychiatric disorders
Chaki, S. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06767-1 · Cited by 10
Morales‐Mulia, M. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172761 · Cited by 10
Illenberger, J. M., Flores‐Ramirez, F. J., Pascasio, G., Franco, M., Mendonsa, B., & Martin‐Fardon, R. (2024) · Journal of Psychopharmacology · doi:10.1177/02698811241260989 · Cited by 9
Reid, M. J., Dunn, K. E., Abraham, L., Ellis, J. D., Hunt, C., Gamaldo, C. E., Coon, W. G., Mun, C. J., Strain, E. C., Smith, M. T., et al. (2024) · SLEEP · doi:10.1093/sleep/zsae025 · Cited by 9
Drug addiction co-morbidity with alcohol: Neurobiological insights
McGinn, M. A., Pantazis, C. B., Tunstall, B. J., Marchette, R. C. N., Carlson, E. R., Said, N., Koob, G. F., & Vendruscolo, L. F. (2021) · International review of neurobiology · doi:10.1016/bs.irn.2020.11.002 · Cited by 11
Role of Lateral Hypothalamic Orexin (Hypocretin) Neurons in Alcohol Use and Abuse: Recent Advances
Walker, L. C., Ch’ng, S. S., & Lawrence, A. J. (2016) · Current Pharmacology Reports · doi:10.1007/s40495-016-0069-7 · Cited by 7
Self-citationMa, Y., Sardar, H., Benabou, M. E., Yu, A. C., Morningstar, A. R., Fajardo, R. N., Kandil, I. F., Rogers, E. T., Vassalli, A., Kauer, J. A., et al. (2025) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2025.100617 · Cited by 6
Lay, B. P. P., & Khoo, S. Y. (2021) · Neuroanatomy and Behaviour · doi:10.35430/nab.2021.e18 · Cited by 4
Self-citationFlores‐Ramirez, F. J., Pascasio, G., & Martin‐Fardon, R. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1718540 · Cited by 3
Cruise, S. C., Secci, M. E., Kelley, L. K., Sharfman, N. M., Rodríguez‐Graciani, K. M., Wills, T. A., Gilpin, N. W., & Avegno, E. M. (2025) · Advances in Drug and Alcohol Research · doi:10.3389/adar.2025.14199 · Cited by 3
Hypocretin Receptor 1 Regulation of Dopamine Neurotransmission and Motivated Behavior
Shaw, J. K., Black, E. M., Zhang, Y., & España, R. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813751-2.00005-x · Cited by 3
Berry, E. A., Huhulea, E. N., Ishibashi, M., McGregor, R., Siegel, J. M., & Leonard, C. S. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.0563-25.2025 · Cited by 3
Medication for Sleep Problems in Posttraumatic Stress Disorder
de Jong, J., & Vermetten, E. H. G. J. M. (2017) · Springer eBooks · doi:10.1007/978-1-4939-7148-0_29 · Cited by 2
Neuropsychiatric and Neurobehavioral Syndromes of the Human Hypothalamus
Wagner, J. H., Sarfraz, N., Maini, K., & Edinoff, A. N. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-030-62187-2_8 · Cited by 1
Flores‐Ramirez, F. J., Illenberger, J. M., & Martin‐Fardon, R. (2024) · Neurobiology of Stress · doi:10.1016/j.ynstr.2024.100695 · Cited by 1
Amodeo, L. R., Wills, D. N., Benedict, J., & Ehlers, C. L. (2025) · Alcohol · doi:10.1016/j.alcohol.2025.01.006 · Cited by 1
The Role of Ghrelin in Reward-Based Feeding
St-Onge, V. (2014) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2014-10569 · Cited by 1
Phospholipase Cascades in OX1 Orexin Receptor Signaling
Jäntti, M. H. (2014)
Orexin/Hypocretin System and Drug Addiction
Matzeu, A., & Martin‐Fardon, R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800634-4.00015-9
Czora-Poczwardowska, K., Kujawski, R., Słyńko-Krzyżostaniak, J., Mikołajczak, P. Ł., & Szulc, M. (2021) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.2478/ahem-2021-0007
(2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816793-9.00001-3
de Lecea, L. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726881621.793550004
de Lecea, L. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726068380.793550010
Berry, E. A., Huhulea, E. N., Ishibashi, M., McGregor, R., Siegel, J. M., & Leonard, C. S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.20.644444
Investigating the effects of orexin receptor 1 antagonism on decision making under uncertainty
Metha, J. A., Bertheau, M., Murawski, C., Hoyer, D., & Jacobson, L. H. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115691
Ostos‐Valverde, A., Daval-Marín-Lozano, V., Gómez‐Villatoro, J. P., Méndez‐Díaz, M., Herrera-Solís, A., Ruiz‐Contreras, A. E., & García, Ó. P. (2025) · Revista de la Facultad de Medicina UNAM · doi:10.22201/fm.24484865e.2025.68.6.02
Holguin, G., & Martin‐Fardon, R. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1729040
Ray, L. A., Nieto, S. J., Miotto, K. A., Mooney, L. J., LeBeau, R. T., Yoon, J. H., Schmitz, J. M., Acierno, R. E., Bailey, N. W., Jenkins, J., et al. (2026) · Trials · doi:10.1186/s13063-026-09489-7
Metadata
- Authors
- Brown, R. M., Khoo, S. Y.-S., & Lawrence, A. J.
- Affiliations
- Medical University of South Carolina (US)
- The University of Melbourne (AU)
- Corresponding author
- Lawrence, Andrew John
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-10-01
- Volume
- 16
- Issue
- 9
- Pages
- 2067-2079
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W1987854393
- Cited by
- 101
- References
- 75
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 6 · 2023: 2 · 2022: 5 · 2021: 10 · 2020: 8 · 2019: 9 · 2018: 10 · 2017: 6 · 2016: 12 · 2015: 10 · 2014: 10 · 2013: 1
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Funders
- State Government of Victoria
- Medical Research Council
- National Health and Medical Research Council (1021227)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- orexin receptor 2, TCS OX2 29, ethanol self-administration, ethanol seeking, cue-induced reinstatement, nucleus accumbens, nucleus accumbens shell, nucleus accumbens core, ethanol reinforcement, sucrose self-administration, alcoholism, G protein-coupled receptors
- MeSH terms
- Orexin Receptor Antagonists, Alcohol Drinking, Ethanol, Animals, Behavior, Animal, Brain, Conditioning, Psychological, Cues, Isoquinolines, Male, Motor Activity, Pyridines, Reward, Self Administration, Sucrose, Rats, Drug-Seeking Behavior, Orexin Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review